SCHEMBL19984157

SCHEMBL19984157

C=C(C)N(C)CCN1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GLA P06280 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KEAP1 Q14145 1/20 0.38
PAOX Q6QHF9 1/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 1/20 0.36
DUSP3 P51452 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
RAB9A P51151 1/20 0.36
USP2 O75604 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
PKM P14618 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14344805 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EGLASMN1; SMN2KEAP1
SCHEMBL259485 0.81 GLA (0.47) ALDH1A1KDM4EGLASMN1; SMN2PAOX
SCHEMBL26579714 0.78 GLA (0.52) ALDH1A1KDM4EGLASMN1; SMN2MEN1
SCHEMBL3673101 0.76 GLA (0.46) ALDH1A1KDM4EGLASMN1; SMN2PAOX
SCHEMBL13690376 0.76 ALDH1A1 (0.48) ALDH1A1KDM4EGLASMN1; SMN2KEAP1
SCHEMBL22874124 0.76 ALDH1A1 (0.35) ALDH1A1KDM4EGLASMN1; SMN2KEAP1
SCHEMBL791912 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EGLASMN1; SMN2KEAP1
SCHEMBL154374 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EGLASMN1; SMN2KEAP1
SCHEMBL7003667 0.75 GLA (0.44) ALDH1A1KDM4EGLASMN1; SMN2TSHR
SCHEMBL11244061 0.75 CA12 (0.47) ALDH1A1KDM4EGLASMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180079727-A1 9-MEMBERED FUSED RING DERIVATIVE SHIONOGI & CO., LTD. (JP) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180079727-A1 9-MEMBERED FUSED RING DERIVATIVE ACSS2, AGTR2, ACSL3 ALDH1A1 365/4885KDM4E 2373/4885GLA 3283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.